Mobio Technologies
Mobio Technologies
Type of Funding
Venture Capital
Max Funding
N/A
Region
Federal/National
Application Difficuty
Fairly simple
Processing Time
Slow (A few months)
Province
All Of Canada
Industry
Other.
Funding Goals
Start-up Funding.
Demographic
N/A
Incorporated
No
Contact
laurie@mobio.net
Apply For A Loan
Business location – Canada
Monthly Revenue – $10K +
Time in Business – 6 months +
Funds in 24 hours
$10,000 to $800,000
Details
Mobio Technologies (formerly known as LX Ventures) is a publicly-traded incubator that launches, acquires, and integrates early-stage, high-growth technology companies.
The company’s vision is to gain early entry and significant ownership into a diversified number of high-growth tech companies from around the world.
Mobio Technologies was founded in 2012 and is based in Vancouver, British Columbia.
Eligibility
Early stage companies
Similar funding programs
Venture Capital
EVP is an early-stage technology venture capital firm focused on pre-seed & seed startups in the Toronto-Waterloo corridor.
With three funds under management, EVP has achieved superior investment returns while helping launch and grow more than 100 companies and over 3,000 well-paying technology jobs in Canada.
EVP seeks out companies with creative intelligence with capital efficient models and large addressable market opportunities.
Max Funding N/A
Extreme Venture Partners
Venture Capital
Whitecap Venture Partners is an early stage venture capital fund investing in high growth companies across three verticals: Information Communications Technology (ICT), Food Technology, Medical Technology
The Whitecap Venture Partners team is a group of former operators and investors who have invested together for over 30 years.
Max Funding N/A
Whitecap
Venture Capital
Based in Montréal, CTI Life Sciences, a Canadian venture firm makes venture capital investments in high quality emerging life sciences companies at the pre-clinical and clinical development stage in Canada and in the U.S.
CTI Life Sciences currently manage $245 million of assets.
Max Funding N/A
CTI Life Sciences